Quarterly report pursuant to Section 13 or 15(d)

NATURE OF OPERATIONS AND SIGNIFICANT ACCOUNTING POLICIES (Tables)

v3.21.2
NATURE OF OPERATIONS AND SIGNIFICANT ACCOUNTING POLICIES (Tables)
6 Months Ended
Jun. 30, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
SCHEDULE OF ANTIDILUTIVE SECURITIES EXCLUDED FROM COMPUTATION OF EARNINGS PER SHARE

 

We do not include the potential impact of dilutive securities in diluted net loss per share, as the impact of these items is anti-dilutive. Potential dilutive securities result from outstanding stock options, restricted stock and “non-pre-funded” warrants. We did not include the following potentially dilutive securities in the computation of diluted net loss per common share during the periods presented:

 

    For the three months ended
June 30,
    For the six months ended
June 30,
 
    2021     2020     2021     2020  
Stock options     7,726,468       7,790,596       7,726,468       7,790,596  
Restricted stock     3,328,125       1,083,313       3,328,125       1,083,313  
Warrants     -       20,000       -       20,000  
Total     11,054,593       8,893,909       11,054,593       8,893,909